Sodium-Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes Mellitus and Liver Cirrhosis: A Systematic Review and Meta-Analysis. [PDF]
CureusShetty USA +7 more
europepmc +1 more source
Multicomponent Salts of the Antidiabetic Agent Saxagliptin: Hydration-Assisted Assembly and Lipophilic Aggregation with Carboxylic Acids. [PDF]
ACS OmegaColatrella AE +5 more
europepmc +1 more source
Dipeptidyl Peptidase 4 Inhibitors: Novel Therapeutic Agents in the Management of Type II Diabetes Mellitus. [PDF]
Pharmacoepidemiol Drug SafAloke C +4 more
europepmc +1 more source
Treatment of Youth-Onset Type 2 Diabetes: Focus on SGLT-2 Inhibitor Use. [PDF]
Pediatr DiabetesArslanian S, Barrett T, Shehadeh N.
europepmc +1 more source
Triple oral therapy combining metformin, SGLT-2 and DPP-4 inhibitors versus dual therapy in type 2 diabetes mellitus: A systematic review and meta-analysis. [PDF]
Medicine (Baltimore)Malik AF +10 more
europepmc +1 more source
Cardiovascular Sequel in Type-2 Diabetes Mellitus Patients on Various Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systemic Review and Meta-Analysis. [PDF]
CureusPrakash V, Goel N.
europepmc +1 more source
Phosphatidylinositol-3-kinase/Protein Kinase B (PI3K/AKT) and Nucleotide-Binding Oligomerization Domain-like Receptor Family Pyrin Domain Containing 3 (NLRP3) Inflammasome Modulation Underlies the Neuroprotective Effects of Vildagliptin in a Rotenone-Induced Mouse Model of Parkinson's Disease. [PDF]
ACS Pharmacol Transl SciPatel D +4 more
europepmc +1 more source
Toxicological profile of anti-diabetic drugs and emerging measures to reduce the toxic burden. [PDF]
Toxicol RepDugbartey GJ +5 more
europepmc +1 more source